PAR14 COST MINIMIZATION ANALYSIS OF RITUXIMAB VERSUS INFLIXIMAB, ADALIMUMAB AND ETANERCEPT FOR RHEUMATOID ARTHRITIS FROM A PAYER PERSPECTIVE IN BRAZIL

✍ Scribed by MG Saggia; EA Santos; V Nasciben

• Book ID: 119595790
• Publisher: John Wiley and Sons
• Year: 2007
• Tongue: English
• Weight: 70 KB
• Volume: 10
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)64929-7